RECALL: Children's cough syrup recalled by pharmaceutical company
A pharmaceutical company has issued a recall for children's cough syrup that it says may have been sold with a dosing cup with incorrect dose markings, according to a news release.
LOUISVILLE, Ky. (WDRB) -- A pharmaceutical company has issued a recall for children's cough syrup that it says may have been sold with a dosing cup with incorrect dose markings, according to a news release.
"Perrigo Company plc...announced today that...it has initiated a voluntary product recall in the US to the retail level of two batches of its children's guaifenesin grape liquid (100mg/5mL) and three batches of its children's guaifenesin DM cherry liquid (100mg guaifenesin and 5mg dextromethorphan HBr/ 5 ml) sold in four-ounce bottles with dosage cup in a box under the store brand products listed below," the news release states.
Recalled lots, along with their corresponding branded labels, are listed below:
GUAIFENESIN GRAPE LIQ 4 OZ
GUAIFENESIN DM CHRY LIQ 4 OZ
|Topcare||5LK0528, 5LK0630, 5LK0779||03/2017|
Anyone who has products with the corresponding labels and batch numbers, "should discard the dosing device and product and may call Perrigo, toll free, Monday through Friday from 8:00 AM to 10:00 PM EST, at 1-888-345-0479, or visit mucusreliefrecall.com. Consumers should contact their physician or healthcare provider if they have any questions, or if they or their children experience any problem that could possibly be related to this drug product," according to the release.
"There have been no reports of adverse events to Perrigo as a result of the incorrect dosage markings," Perrigo Chairman and CEO Joseph C. Papa stated, according to the news release. "Perrigo is taking this action to maintain the highest possible quality standards for our retail customers and consumers. We are taking this action because it is the right thing to do."
Copyright 2016 by WDRB News. All rights reserved.